Cytotoxic activity evaluation and QSAR study of chromene-based chalcones

Archives of Pharmacal Research

Volumn 35, Issue 12, 2012, Pages 2117-2125

  Firoozpour, Loghman ^a   Edraki, Najmeh ^a,b   Nakhjiri, Maryam ^c   Emami, Saeed ^d   Safavi, Maliheh ^c,e   Ardestani, Sussan Kabudanian ^e   Khoshneviszadeh, Mehdi ^a,b   Shafiee, Abbas ^c   Foroumadi, Alireza ^a,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Chalcones; Chromene; Cytotoxic activity; QSAR

Indexed keywords

ANTINEOPLASTIC AGENT; CHALCONE DERIVATIVE; CHROMENE DERIVATIVE; ETOPOSIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; HYDROPHOBICITY; IC 50; IN VITRO STUDY; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; THIN LAYER CHROMATOGRAPHY;

ANTINEOPLASTIC AGENTS; BENZOPYRANS; BREAST NEOPLASMS; CHALCONES; CYTOTOXINS; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMANS; MCF-7 CELLS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84873409450     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-012-1208-2     Document Type: Article

References (41)

1. Akbarzadeh, T.; Rafinejad, A.; Mollaghasem, J. M.; Safavi, M.; Fallah-Tafti, A.; Pordeli, M.; Ardestani, S. K.; Shafiee, A.; and Foroumadi, A.; 2-Amino-3-cyano-4-(5-arylisoxazol-3-yl)-4H-chromenes: Synthesis and in vitro cytotoxic activity. Arch. Pharm. (Weinheim), 345, 386-392 (2012).
2. Akihisa, T.; Tokuda, H.; Hasegawa, D.; Ukiya, M.; Kimura, Y.; Enjo, F.; Suzuki, T.; and Nishino, H.; Chalcones and other compounds from the exudates of Angelica keiskei and their cancer chemopreventive effects. J. Nat. Prod.; 69, 38-42 (2006). (Pubitemid 43241751)
3. Alizadeh, B. H.; Foroumadi, A.; Emami, S.; Khoobi, M.; Panah, F.; Ardestani, S. K.; and Shafiee, A.; Isochaihulactone analogues: synthesis and anti-proliferative activity of novel dibenzylbutyrolactones. Eur. J. Med. Chem.; 45, 5979-5984 (2010).
4. Belluti, F.; Fontana, G.; Dal, B. O. L.; Carenini, N.; Giommarelli, C.; and Zunino, F.; Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: Identification of novel proapoptotic agents. Bioorg. Med. Chem.; 18, 3543-3550 (2010).
5. Bois, F.; Boumendjel, A.; Mariotte, A. M.; Conseil, G.; and Di Petro, A.; Synthesis and biological activity of 4-alkoxy chalcones: potential hydrophobic modulators of P-glycoprotein-mediated multidrug resistance. Bioorg. Med. Chem.; 7, 2691-2695 (1999). (Pubitemid 30105841)
6. Dimmock, J. R.; Elias, D. W.; Beazely, M. A.; and Kandepu, N. M.; Bioactivities of chalcones. Curr. Med. Chem. 6, 1125-1149 (1999).
7. Dimmock, J. R.; Kandepu, N. M.; Hetherington, M.; Quail, J. W.; Pugazhenthi, U.; Sudom, A. M.; Chamankhah, M.; Rose, P.; Pass, E.; Allen, T. M.; Halleran, S.; Szydlowski, J.; Mutus, B.; Tannous, M.; Manavathu, E. K.; Myers, T. G.; Clercq, E. D.; and Balzarini, B.; Cytotoxic activities of mannich bases of chalcones and related compounds. J. Med. Chem.; 4, 1014-1026 (1998). (Pubitemid 28207377)
8. Foroumadi, A.; Emami, S.; Sorkhi, M.; Nakhjiri, M.; Nazarian, Z.; Heydari, S.; Ardestani, S. K.; Poorrajab, F.; and Shafiee, A.; Chromene-based synthetic chalcones as potent antileishmanial agents: Synthesis and biological activity. Chem. Biol. Drug. Des.; 75, 590-596 (2010).
9. Frisch, M. J.; Trucks, M. J.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Zakrzewski, V. G.; Montgomery, J. A.; Stratmann, J. R.; Burant, J. C.; Dapprich, S.; Millam, J. M.; Daniels, A. D.; Kudin, K. N.; Strain, M. C.; Farkas, O.; Tomasi, J.; Barone, V.; Cossi, M.; Cammi, R.; Mennucci, B.; Pomelli, C.; Adamo, C.; Clifford, S.; Ochterski, J.; Petersson, G. A.; Ayala, P. Y.; Cui, Q.; Morokuma, K.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Cioslowski, J.; Ortiz, J. V.; Baboul, A. G.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Gomperts, R.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Gonzalez, C.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Andres, J. L.; Gonzalez, C.; Head-Gordon, M.; Replogle, E. S.; and Pople, J. A.; Gaussian 98, Revision A.7, Gaussian, Inc.; Pittsburgh P. A. (1998).
10. Go, M. L.; Wu, X.; and Liu, X. L.; Chalcones: an update on cytotoxic and chemopretective properties. Curr. Med. Chem.; 12, 483-499 (2005). (Pubitemid 40305634)
11. Gunatilaka, A. L.; Kingston, D. G. I.; and Johnson, R. K.; Mechanism-based isolation and structures of some anticancer active natural products. Pure Appl. Chem.; 66, 2219-2222 (1994).
12. Hadfield, J. A.; Ducki, S.; Hirst, N.; and McGown, AT.; Tubulin and microtubules as target for anticancer drugs. Prog. Cell Cycle Res.; 5, 309-325 (2003).
13. Heo, S. J.; Kim, K. N.; Yoon, W. J.; Oha, C.; Choi, Y. U.; Affan, A.; Lee, Y. J.; Lee, H. S.; and Kang, D. H.; Chromene induces apoptosis via caspase-3 activation in human leukemia HL-60 cells. Food Chem. Toxicol.; 49, 1998-2004 (2011).
14. Huang, W.; Ding, Y.; Miao, Y.; Liu, M. Z.; Li, Y.; and Yang, G. F.; Synthesis and antitumor activity of novel dithiocarbamate substituted chromones. Eur. J. Med. Chem.; 44, 3687-3696 (2009).
15. Hughes, G. K.; Lahey, F. N.; Price, J. R.; and Webb, L. J.; Alkaloids of the Australian Rutaceae. Nature, 162, 223-224 (1948).
16. Lawrence, N. J.; McGown, A. T.; Ducki, S.; and Hadfield, J. A.; The interaction of chalcones with tubulin. Anticancer Drug Des.; 15, 135-141 (2000). (Pubitemid 30410472)
17. Lawrence, N. J. and McGown, A. T.; The chemistry and biology of antimitotic chalcones and related enone systems. Curr. Pharm. Des.; 11, 1679-1693 (2005). (Pubitemid 40668144)
18. Liu, M.; Wilairat, P.; and Croft, S. L.; Structure-activity relationships of antileishmanial and antimalarial chalcones. Bioorg. Med. Chem.; 11, 2729-2738 (2003). (Pubitemid 36682997)
19. Liu, Q.; Wang, Y. F.; Chen, R. J.; Zhang, M. Y.; Wang, Y. F.; Yang, C. R.; and Zhang, Y. J.; Anti-Coxsackie virus B3 norsesquiterpenoids from the roots of Phyllanthus emblica. J. Nat. Prod.; 72, 969-972 (2009).
20. Liu, X. L.; Tee, H. W.; and Go, M. L.; Functionalized chalcones as selective inhibitors of P-glycoprotein and breast cancer resistance protein. Bioorg. Med. Chem.; 16, 171-180 (2008).
21. Mager, H.; The problem of multicollinearity in Hansch-type quantitative structure-activity relationships (QSAR) and in chemical linear free energy relationships (LFER). Pharmazie, 38, 120-128 (1983).
22. Mahmoodi, M.; Aliabadi, A.; Emami, S.; Safavi, M.; Rajabalian, S.; Mohagheghi, M. A.; Khoshzaban, A.; Samzadeh-Kermani, A.; Lamei, N.; Shafiee, A.; and Foroumadi, A.; Synthesis and in-vitro cytotoxicity of poly-functionalized 4-(2-arylthiazol-4-yl)-4H-chromenes. Arch. Pharm. (Weinheim), 343, 411-416 (2010).
23. Mao, W.; Wang, T.; Zeng, H.; Wang, Z.; Chen, J.; and Shen, J.; Synthesis and evaluation of novel substituted 5-hydroxycoumarin and pyranocoumarin derivatives exhibiting significant antiproliferative activity against breast cancer cell lines. Bioorg. Med. Chem. Lett.; 19, 4570-4573 (2009).
24. Mayur, Y. C.; Peters, G. J.; Prasad, V. V.; Lemo, C.; and Sathish, N. K.; Design of new drug molecules to be used in reversing multidrug resistance in cancer cells. Curr. Cancer Drug Targets, 9, 298-306 (2009).
25. Mosmann, T.; Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immun. Methods, 65, 55-63 (1983). (Pubitemid 14203433)
26. Nakatani, N.; Ichimaru, M.; Moriyasu, M.; and Kato, A.; Induction of apoptosis in human promyelocytic leukemia cell line HL-60 by C-benzylated dihydrochalcones, uvaretin, isouvaretin and diuvaretin. Biol. Pharm. Bull.; 28, 83-86 (2005). (Pubitemid 40879788)
27. Nazarian, Z.; Emami, S.; Heydari, S.; Ardestani, S. K.; Nakhjiri, M.; Poorrajab, F.; and Shafiee, A.; Novel antileishmanial chalconoids: Synthesis and biological activity of 1- or 3-(6-chloro-2H-chromen-3-yl)propen-1-ones. Eur. J. Med. Chem.; 45, 1424-1429 (2010).
28. Nowakowska, Z.; A review of antiinfective and anti-inflammatory chalcones. Eur. J. Med. Chem.; 42, 125-137 (2007). (Pubitemid 46282233)
29. Park, E. J.; Park, H. R.; Lee, J. S.; and Kim, J.; Lichochalcone A: an inducer of cell differentiation and cytotoxic agent from Pogostemon cablin. Planta Med.; 64, 464-466 (1998). (Pubitemid 28298706)
30. Patil, C. B.; Mahajan, S. K.; and Katti, S. A.; Chalcone: A versatile molecule. J. Pharm. Sci. Res.; 1, 11-22 (2009).
31. Reddy, M. V.; Su, C. R.; Chiou, W. F.; Liu, Y. N.; Chen, R. Y.; Bastow, K. F.; Lee, K. H.; and Wu, T. S.; Design, synthesis, and biological evaluation of Mannich bases of heterocyclic chalcone analogs as cytotoxic agents. Bioorg. Med. Chem.; 16, 7358-7370 (2008).
32. Reddy, M. V.; Shen, Y. C.; Yang, J. S.; Hwang, T. L.; Bastow, K. F.; Qian, K.; Lee, K. H.; and Wu, T. S.; New bichalcone analogs as NF-κB inhibitors and as cytotoxic agents inducing Fas/CD95-dependent apoptosis. Bioorg. Med. Chem.; 19, 1895-1906 (2011).
33. Rojas, J.; Paya, M.; Dominguez, J. N.; and Ferrandiz, M. L.; The synthesis and effect of fluorinated chalcone derivatives on nitric oxide production. Bioorg. Med. Chem. Lett.; 12, 1951-1954 (2002). (Pubitemid 34756456)
34. Rozmer, Z.; Berki, T.; and Perjési, P.; Different effects of two cyclic chalcone analogues on cell cycle of Jurkat T cells. Toxicol. In Vitro, 20, 1354-1362 (2006). (Pubitemid 44537661)
35. Sashidhara, K. V.; Kumar, A.; Kumar, M.; Sarkar, J.; and Sinha, S.; Synthesis and in vitro evaluation of novel coumarin-chalcone hybrids as potential anticancer agents Bioorg. Med. Chem. Lett.; 20, 7205-7211 (2010a).
36. Sashidhara, K. V.; Rosaiah, J. N.; Kumar, M.; Gara, R. K.; Nayak, L. V.; Srivastava, K.; Bid, H. K.; and Konwar, R.; Neo-tanshinlactone inspired synthesis, in vitro evaluation of novel substituted benzocoumarin derivatives as potent anti-breast cancer agents. Bioorg. Med. Chem. Lett.; 20, 7127-7131 (2010b).
37. Sharma, G. N.; Dave, R.; Sanadya, J.; Sharma, P.; and Sharma, K. K.; Various types and management of breast cancer: an overview. J. Adv. Pharm. Technol. Res.; 1, 109-126 (2010).
38. Sivakumar, P. M.; Priya, S.; and Doble, M.; Synthesis, biological evaluation, mechanism of action and quantitative structure-activity relationship studies of chalcones as antibacterial agents. Chem. Biol. Drug Des.; 73, 403-415 (2009).
39. Zhang, Y.; Shi, S.; Zhao, M.; Jiang, Y.; and Tu, P.; A novel chalcone from Coreopsis tinctoria nutt. Biochem. Syst. Ecol.; 34, 766-769 (2006). (Pubitemid 44108449)
40. Zhou, Z. Z.; Huang, W.; Ji, F. Q.; Ding, M. W.; and Yang, G. F.; Construction of a combinatorial library of 2-(4-oxo-4H-1-benzopyran-3-yl)-4- thiazolidinones by microwave-assisted one-pot parallel syntheses. Heteroatom Chem.; 18, 381-389 (2007). (Pubitemid 46854288)
41. Yayli, N.; Ucuncu, O.; Yasar, A.; Gok, Y.; Kucuk, M.; and Kolayli, S.; Stereoselective photochemistry of methoxy chalcones in solution and their radical scavenging activity. Turk. J. Chem.; 28, 515-521 (2004). (Pubitemid 39407067)